Cancer World Newsletter - Time to act on trials PDF Print E-mail
Great opportunities to get better results for patients are being lost because of a collective
failure to organise clinical trials that can get answers to urgent questions about how best
to use therapies and in whom. This editorial argues against sitting back and waiting for the
Clinical Trials Directive to be overhauled. As has been shown in the UK, which has seen a
quadrupling of the proportion of cancer patients in trials over the past decade, much can –
and must – be done now to boost enrolment in trials across Europe.

 What do you think?

  • Is enough being done in your hospital, health region or country to promote clinical trials?
  • What in your experience are the biggest barriers to setting up trials and enrolling patients?
 You can read the article here. Press the comment button at the end and share your views.